359 related articles for article (PubMed ID: 29204251)
1. Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective.
Tian J; Zhao Y; Liu Y; Liu Y; Chen K; Lyu S
Oxid Med Cell Longev; 2017; 2017():8214541. PubMed ID: 29204251
[TBL] [Abstract][Full Text] [Related]
2. The Role of ERK1/2 in the Development of Diabetic Cardiomyopathy.
Xu Z; Sun J; Tong Q; Lin Q; Qian L; Park Y; Zheng Y
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941647
[TBL] [Abstract][Full Text] [Related]
3. The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy.
Wang S; Ding L; Ji H; Xu Z; Liu Q; Zheng Y
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376265
[TBL] [Abstract][Full Text] [Related]
4. [Effect of mitochondrial dysfunction in diabetic cardiomyopathy and intervention of traditional Chinese medicine].
Tian J; Lv R; Guo W
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):8-14. PubMed ID: 29552805
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
[TBL] [Abstract][Full Text] [Related]
6. Early administration of trimetazidine attenuates diabetic cardiomyopathy in rats by alleviating fibrosis, reducing apoptosis and enhancing autophagy.
Zhang L; Ding WY; Wang ZH; Tang MX; Wang F; Li Y; Zhong M; Zhang Y; Zhang W
J Transl Med; 2016 Apr; 14(1):109. PubMed ID: 27121077
[TBL] [Abstract][Full Text] [Related]
7. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
[TBL] [Abstract][Full Text] [Related]
8. Cortex Mori Radicis extract attenuates myocardial damages in diabetic rats by regulating ERS.
Lian J; Chen J; Yuan Y; Chen J; Daud M Sayed M; Luo L; Zhu Y; Li S; Bu S
Biomed Pharmacother; 2017 Jun; 90():777-785. PubMed ID: 28427040
[TBL] [Abstract][Full Text] [Related]
9. Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system.
Sukumaran V; Gurusamy N; Yalcin HC; Venkatesh S
Pflugers Arch; 2022 Jan; 474(1):63-81. PubMed ID: 34967935
[TBL] [Abstract][Full Text] [Related]
10. Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy.
Parim B; Sathibabu Uddandrao VV; Saravanan G
Heart Fail Rev; 2019 Mar; 24(2):279-299. PubMed ID: 30349977
[TBL] [Abstract][Full Text] [Related]
11. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
[TBL] [Abstract][Full Text] [Related]
12. Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: A molecular landscape.
Haye A; Ansari MA; Rahman SO; Shamsi Y; Ahmed D; Sharma M
Eur J Pharmacol; 2020 Dec; 888():173376. PubMed ID: 32810493
[TBL] [Abstract][Full Text] [Related]
13. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Jia G; Hill MA; Sowers JR
Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
15. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
16. Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.
Huang R; Shi Z; Chen L; Zhang Y; Li J; An Y
Eur J Pharmacol; 2017 Nov; 814():151-160. PubMed ID: 28826911
[TBL] [Abstract][Full Text] [Related]
17. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: induced diabetic cardiomyopathy.
Zhang N; Yang Z; Xiang SZ; Jin YG; Wei WY; Bian ZY; Deng W; Tang QZ
Mol Cell Biochem; 2016 Jun; 417(1-2):87-96. PubMed ID: 27160937
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy.
Tang Z; Wang P; Dong C; Zhang J; Wang X; Pei H
Oxid Med Cell Longev; 2022; 2022():5913374. PubMed ID: 35103095
[TBL] [Abstract][Full Text] [Related]
20. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
Khan S; Ahmad SS; Kamal MA
Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
